Intranasal Drug Delivery Devices Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theIntranasal Drug Delivery Devices Market?
The escalating rate of chronic diseases is anticipated to stimulate the expansion of the intranasal drug delivery devices market. Chronic illnesses are defined as those that endure for a year or longer, necessitating ongoing medical care, hinder everyday activities, or both. Intranasal drug delivery devices offer a non-intrusive and effective strategy for dispensing medicines to manage chronic ailments. These devices enable direct medication delivery to the problem site, which is straightforward, promotes swift absorption, and is user-friendly. For example, according to the UK-based National Health Service, in June 2024, the NHS recorded an additional 549,000 individuals in England in 2023 who were at risk of developing type 2 diabetes. This increased the total number of pre-diabetic patients, or those with non-diabetic hyperglycemia, registered with a GP to 3,615,330, up nearly 20% from 3,065,825 in 2022. Consequently, the intranasal drug delivery devices market growth is driven by the escalating rate of chronic diseases.
Intranasal Drug Delivery Devices Market Driver: Rise in Preference for Non-Invasive Drug Delivery Boosts Intranasal Drug Delivery Device Market Growth
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp
#What Long-Term Growth Rate is Expected for theIntranasal Drug Delivery Devices Market Between 2025 and 2034?
The market size for intranasal drug delivery devices has experienced robust growth in recent times. Its value is projected to rise from $60.27 billion in 2024 to $65.59 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.8%. This growth during the historic period is a result of various factors such as an increase in chronic respiratory diseases, preference and compliance among patients, the convenience of self-administration, pediatric applications, expansion of the market in allergic rhinitis treatment, and a broader spectrum of indications.
The market for intranasal drug delivery devices is anticipated to experience significant expansion in the upcoming years, reaching $92.05 billion in 2029 with an 8.8% compound annual growth rate (CAGR). Such predicted growth over the future period can be credited to factors such as an increasing old-age population, a rise in global respiratory conditions, an expansion in usage for neurological disorders, a drive towards personalized medicine, preventive healthcare initiatives, and winning ground in emerging economies. Key trends to watch for over this projected period include advancements in formulation technology, an emphasis on uses for pediatrics and the elderly, an increase in self-use devices, nasal powder inhalers, and the inclusion of biologics and peptides.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13463
What Are the Current Market Growth and Trends in theIntranasal Drug Delivery Devices Market That Industry Players Should Watch?
Leading companies in the nasal drug delivery technology market, such as major pharmaceutical corporations, are continually innovating and upgrading their product offerings. They aim to introduce novel drug administration methods to retain their market dominance. To illustrate, AptarGroup, Inc., an American pharmaceutical and drug delivery company, unveiled APF Futurity, the first-ever recyclable, metal-free, multidose nasal spray in January 2023. The product is specifically designed to administer nasal saline and comparable over-the-counter (OTC) formulations. Made from polyolefin materials and free from any metal parts or recycling disruptors, APF Futurity mitigates the necessity for separation in recycling streams and encourages the use of higher quality recycled materials. What sets this product apart is its focus on recyclability; it is an exceptionally recyclable nasal spray pump with a Class AA certification from cyclos-HTP for recycling streams in Europe.
What Are the Major Market Players Making an Impact on theIntranasal Drug Delivery Devices Market Growth?
Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Intranasal Drug Delivery Devices Market Driving Opportunities and Innovations?
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theIntranasal Drug Delivery Devices Market?# Market Expansion?
North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Intranasal Drug Delivery Devices Market 2025, By The Business Research Company:
ENT Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report
Fetal And Neonatal Monitoring Devices Global Market Report 2024
Hematology Diagnostic Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
